Evaluating Causal Effects of Gut Microbiome on Bipolar Disorder
Bipolar Disorders · 2025-12 · 27 (8) · 551-556
DOI: 10.1111/bdi.70063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bipolar Disorders, 2025-09. Verfasst von Qian Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Bipolar Disorder, Dysbiosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Background
Previous studies have shown that gut microbiome dysbiosis has pathogenic significance in the development of bipolar disorder (BD), but the direct causal relationship remains unclear. We aimed to investigate this potential correlation.
Methods
Using a two‐sample Mendelian randomization (TSMR) analysis, we examined the potential causal effects of gut microbiota on BD. Summary results for gut microbiota were derived from two large genome‐wide association studies (GWAS) on gut microbiota: the MibioGen consortium ( N = 18,340) and the Dutch Microbiome Project ( N = 8208), as well as one GWAS summary result for BD ( N = 413,466).
Results
Our TSMR analysis revealed that the levels of 12 taxa were associated with a reduced risk of BD. These included the phylum Bacteroidetes , its class Bacteroidia , its order Bacteroidales , its species Parabacteroides johnsonii and Paraprevotella unclassified , and genus Faecalibacterium (OR: 0.85 ~ 0.96, p ≤ 0.043). Conversely, 11 gut bacterial taxa were linked to an increased risk of BD. These comprised the class Betaproteobacteria , its order Burkholderiales , and its family Sutterellaceae (OR: 1.06 ~ 1.25, p ≤ 0.049).
Conclusions
Our study further identifies a genetic link between BD and gut microbiota. The causal effects of certain gut microbiota on BD may bring potential clinical benefits and provide a new paradigm for the prevention and treatment of BD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
- School of Systems Biology, George Mason University, Fairfax, USA.
- Research Centre for Medical Genetics, Moscow, Russia.
- Institute of Neuropsychiatry, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
ORCID-Profile: Fuquan Zhang
Zitieren
APA
Zhao, Q., Cao, H., Baranova, A., & Zhang, F. (2025). Evaluating Causal Effects of Gut Microbiome on Bipolar Disorder. Bipolar Disorders, 27(8), 551-556. https://doi.org/10.1111/bdi.70063
Vancouver
Zhao Q, Cao H, Baranova A, Zhang F. Evaluating Causal Effects of Gut Microbiome on Bipolar Disorder. Bipolar Disorders. 2025;27(8):551-556. doi:10.1111/bdi.70063
BibTeX
@article{Zhao2025,
author = {Zhao, Qian and Cao, Hongbao and Baranova, Ancha and Zhang, Fuquan},
title = {Evaluating Causal Effects of Gut Microbiome on Bipolar Disorder},
journal = {Bipolar Disorders},
year = {2025},
volume = {27},
number = {8},
pages = {551--556},
doi = {10.1111/bdi.70063}
}
EUVIMED